Last reviewed · How we verify
Placebo for Propofol
A placebo control has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect.
A placebo control has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect. Used for Control arm in propofol efficacy and safety trials.
At a glance
| Generic name | Placebo for Propofol |
|---|---|
| Sponsor | Maharashtra University of Health Sciences |
| Modality | Small molecule |
| Therapeutic area | Clinical Trial Control |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to establish the true efficacy of an active drug by comparison. Any observed effects in placebo groups are attributed to psychological expectation, natural disease progression, or regression to the mean rather than direct molecular action. Placebo controls are essential for demonstrating that observed benefits in the active treatment group exceed those from non-specific effects.
Approved indications
- Control arm in propofol efficacy and safety trials
Common side effects
Key clinical trials
- Anesthesia-Masked Psilocybin Therapy for Major Depression (PHASE2)
- Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users (PHASE1)
- Dexmedetomidine and Myocardial Protection (NA)
- Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation (NA)
- Esketamine-propofol Versus Propofol for Flexible Bronchoscopy (PHASE4)
- Intravenous Administration of Magnesium Sulfate in Laparoscopic Hysterectomy Cases (NA)
- Sevoflurane and Dexmedetomidine's Contrasting Renal Impacts After Non-Cardiac Surgery (NA)
- Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for Propofol CI brief — competitive landscape report
- Placebo for Propofol updates RSS · CI watch RSS
- Maharashtra University of Health Sciences portfolio CI